Rituximab and mepolizumab combination therapy for glucocorticoid-resistant myocarditis related to eosinophilic granulomatosis with polyangiitis

K Higashitani, R Yoshimi, Y Sato… - Modern …, 2022 - academic.oup.com
Eosinophilic granulomatosis with polyangiitis (EGPA), which belongs to the anti-neutrophil
cytoplasmic antibody (ANCA)-associated vasculitides, is characterised by eosinophil-rich …

[PDF][PDF] Rituximab and mepolizumab combination therapy for glucocorticoid-resistant myocarditis related to eosinophilic granulomatosis with polyangiitis

K Higashitani, R Yoshimib, Y Satoa, T Watanabea… - 2021 - scholar.archive.org
Eosinophilic granulomatosis with polyangiitis (EGPA), which belongs to the anti-neutrophil
cytoplasmic antibody (ANCA)-associated vasculitides, is characterized by eosinophil-rich …

Rituximab and mepolizumab combination therapy for glucocorticoid-resistant myocarditis related to eosinophilic granulomatosis with polyangiitis.

K Higashitani, R Yoshimi, Y Sato… - Modern Rheumatology …, 2022 - europepmc.org
Eosinophilic granulomatosis with polyangiitis (EGPA), which belongs to the anti-neutrophil
cytoplasmic antibody (ANCA)-associated vasculitides, is characterised by eosinophil-rich …

Rituximab and mepolizumab combination therapy for glucocorticoid-resistant myocarditis related to eosinophilic granulomatosis with polyangiitis

K Higashitani, R Yoshimi, Y Sato, T Watanabe… - Modern Rheumatology …, 2021 - cir.nii.ac.jp
抄録< jats: title> ABSTRACT</jats: title>< jats: p> Eosinophilic granulomatosis with
polyangiitis (EGPA), which belongs to the anti-neutrophil cytoplasmic antibody (ANCA) …

Rituximab and mepolizumab combination therapy for glucocorticoid-resistant myocarditis related to eosinophilic granulomatosis with polyangiitis

K Higashitani, R Yoshimi, Y Sato… - Modern …, 2022 - academic.oup.com
Eosinophilic granulomatosis with polyangiitis (EGPA), which belongs to the anti-neutrophil
cytoplasmic antibody (ANCA)-associated vasculitides, is characterised by eosinophil-rich …

Rituximab and mepolizumab combination therapy for glucocorticoid-resistant myocarditis related to eosinophilic granulomatosis with polyangiitis

K Higashitani, R Yoshimi, Y Sato… - Modern …, 2022 - pubmed.ncbi.nlm.nih.gov
Eosinophilic granulomatosis with polyangiitis (EGPA), which belongs to the anti-neutrophil
cytoplasmic antibody (ANCA)-associated vasculitides, is characterised by eosinophil-rich …